1.The research status and prospect of previously-Irradiated recurrent head and neck carcinoma in radiation therapy
Yufei ZHANG ; Juyi WEN ; Jingbo KANG
China Medical Equipment 2016;13(4):135-138
The treatment of recurrent head and neck cancers has improved from single modality interventions of surgery and radiation therapy alone to include combined modality therapy with surgery, chemotherapy and radiation. Combined therapy has led to improved local control and disease-free survival. New developments in radiation oncology such as intensity-modulated radiotherapy, brachytherapy, stereotactic radiosurgery, fractionated stereotactic radiotherapy, have helped to improve this outlook even further. These recent advances allow for a higher dose to be delivered to the tumor while minimizing the dose delivered to the surrounding normal tissue. This article provides an update of the new developments in radiotherapy in the management of previously-irradiated recurrent head and neck carcinoma.
2.EFFECTS OF REDUCED COENZYME Ⅰ ON REGULATION OF GENE EXPRESSION IN PC12 CELLS DAMAGED BY ROTENONE
Jiren ZHANG ; Juyi WEN ; Men XU
Medical Journal of Chinese People's Liberation Army 1982;0(03):-
To elucidate the mechanism of mitochondrial damage induced by rotenone and the possible biological function of NADH in repairing mitochondrial damage of PC12 cells, cytotoxicity test, immunocytofluorescence and flow cytometric analysis were used to investigate the changes of cell proliferation genes (c myc, c erbB 2), apoptosis inhibition genes bcl 2, p53 tumor suppressor protein, cell immediate early gene (c fos) and proliferating cell nuclear antigen (PCNA) in PC12 cells before and after exposure to rotenone. The results showed that rotenone could significantly inhibit the proliferation rate of PC12 cells and expression of c erbB 2, c myc, p53, and bcl 2 in PC12 cells, NADH could restore the proliferation activity of PC12 cell damaged by rotenone by gene regulation. It is suggested that rotenone could induce PC12 cells apoptosis not only by regulating mitochondria phosphorylation process, but also by down regulating the expression of oncogene proteins (C erbB 2, c myc), anti apoptotic gene protein (bcl 2), p53 tumor suppressor gene protein, and upregulating the expression of the immediate early gene c fos. Regulation of bcl 2, c myc, c erbB 2 and p53 might be involved in the repair of mitochondrial damage of PC12 cells.
3.Comparison study of efficacy evaluation based on RECIST 1.1 and mRECIST in hepato-cellular carcinoma treated with SBRT
Yufei ZHANG ; Jingbo KANG ; Juyi WEN ; Rui DU ; Xinhong ZHANG
Chinese Journal of Clinical Oncology 2016;43(20):902-906
Objective: To compare the difference of Response Evaluation Criteria in Solid Tumors 1.1 (RECIST 1.1) and modified Re-sponse Evaluation Criteria in Solid Tumors (mRECIST) in the treatment of hepatocellular carcinoma (HCC) after stereotactic body radio-therapy (SBRT). Methods:From Janurary 2014 to August 2015, thirty-five patients with HCC treated with SBRT were included in De-partment of Radiation Oncology and Integrative Oncology of Navy General Hospital of PLA, and SBRT efficacy was evaluated based on RECIST 1.1 and mRECIST criteria. Results:Under RECIST 1.1, one patient had complete response (CR), 20 had partial response (PR), and 11 achieved stable disease (SD) at three months. Three patients had progressive disease (PD). The overall best response rate (CR+PR) was 60%. In comparison, under mRECIST, 10 patients had CR, 16 had PR, and 6 achieved SD at three months. Three patients had PD. The overall best response rate was 74.28%. The statistical analysis showed that Kappa=0.402 (χ2=43.3, P<0. 001) was less than 0.75 but greater than 0.4, indicating that it had not reached the two diagnostic criteria of consistency degree of satisfaction. According to the mRECIST criteria, the objective remission group (CR+PR) was superior to the nonobjective remission group (SD+PD) in progression-free survival (P<0.001). Conclusion:For unresectable HCC, mRECIST may be more useful than RECIST 1.1 in evaluating HCC response to SBRT.
4.Hot spots and co-authorship in foreign studies on pancreatic cancer radio chemotherapy in recent 5 years
Wei ZHENG ; Jingbo KANG ; Juyi WEN ; Xinhong ZHANG ; Jing WANG
Chinese Journal of Medical Library and Information Science 2016;25(7):37-43
Objective To collect the hot spots, development trends, high yield authors and their affiliated institutions by analyzing the papers on pancreatic cancer chemotherapy in recent 5 years. Methods The papers on pancreatic cancer chemotherapy were downloaded from PubMed. Their high frequency subject headings extracted by BICOMB were analyzed by bibliometric double clustering analysis and strategic coordinate analysis. The high yield authors were analyzed by co-authorship group analysis. Results The current studies on pancreatic cancer chemotherapy in foreign countries were focused on the pathological features of pancreatic duct adenocarcinoma before and after chemotherapy, drug therapy of pancreatic cancer according to its genetics, metabolism and pharmacology of antitumor drugs, surgical treatment combined with radiotherapy and chemotherapy for pancreatic cancer. The high yield authors could be divided into two large groups from Japan and USA and a number of small groups. Conclusion New breakthrough points should be found from the matured topics, the topics with a further developmental space should be greatly concerned, and cooperation should be strengthened between study groups or teams.
5.A prospective case-control study of the ERPs in depression
Yan SUN ; Li LI ; Kewen WU ; Huijun DUAN ; Weidong SHANG ; Yanfang WANG ; Juyi PENG ; Jintang MA ; Kerang ZHANG
Chinese Journal of Behavioral Medicine and Brain Science 2010;19(10):904-906
Objective To explore the event-related potentials (ERPs) P300 is changeable or not before and after treatment. Methods 99 cases of patients with first onset of depression diagnosed by DSM-Ⅳ as case group,and 100 cases matched with patients as control group were collected. P300 of two groups were obtained before and after treatment for 6 weeks,12 weeks,24 weeks. T test was used to analysis the difference of indicators of P300 among groups; repeated measure analysis of variance was used to analysis the longitudinal changes. Results shorter latency of N2-P3 ( (P < 0.01 ); and lower amplitude of N2, P3, N2-P3 (P < 0. 05 ), higher amplitude of P2-tency and a upward one in N2-P3 latency in the four periods; a upward trend could also be found in P3, N2-P3 amplitude, but there were no statistical differences(P > 0. 05 ). The results of paired-samples t test: P3, N2-P3 amplitude in case group were higher after treatment for 6 weeks than before, the difference was significant (P < 0.01 ); no significant results were found in P300 latency or amplitude between the 62 cases of depression after treatment for 24 weeks and the 65 normal controls selected (P > 0. 05 ). Conclusion P300 latencies and amplitudes tend to be partly recovered after the acute treatment in patients with depression, but after the long-term therapy not clear.
6.Innate immunology research of glutaraldehyde-treated xenogenic blood vessels
Ying ZHANG ; Da GONG ; Yi XIN ; Wei CUI ; Jielin LIU ; Juyi WAN ; Sa LIU ; Diankun LI ; Lanping DU ; Zhifei XIN ; Xiufang XU ; Wenbin LI
Chinese Journal of Immunology 2015;(8):1085-1088,1093
Objective:To conduct a systematic study of the immunologic response of rats to transplanted glutaraldehyde ( GA)-treated porcine blood vessels in vivo.Methods: The experiment was divided into two groups:fresh group and glutaraldehyde-treated group.Twenty cases of fresh and glutaraldehyde-treated porcine pulmonary arteries were subcutaneously embedded in rats.We compared the changes using HE staining and immunohistochemistry.Results:HE staining showed that there were stronger expression on day 12 and day 30 in the fresh group than that in the glutaraldehyde group.There were similar results in morphology in CD68,C3,IgG.The results of integral optical density ( IOD) in immunohistochemistry showed that IOD started rising from day 4 and got the peak on day 12 or day 30 and or fell on day 60.Conclusion: Innate immunity played an important role in the research on xenogenic immunological rejection mechanism.The immunogenicity of glutaraldehyde-treated xenogenic blood vessels is lower than that in fresh blood vessels.However there is still immunogenicity in glutaraldehyde-treated xenogenic blood vessels.We will explore better ways to obviously weaken the rejection.
7.New Requirements and Improvement Suggestion for the Protection of Vulnerable Groups in Ethical Review Measures for Life Science and Medical Research Involving Humans
Zengrui ZHANG ; Ruilin DING ; Juyi WAN ; Jiyin ZHOU
Chinese Medical Ethics 2023;36(10):1110-1115
In February 2023, the National Health Commission, together with the Ministry of Science and Technology, the Ministry of Education, and the State Administration of Traditional Chinese Medicine issued the Ethical Review Measures for Life Science and Medical Research Involving Humans, which emphasizes that research participants involving vulnerable groups such as children, intellectual disabilities, and mental disabilities should be given special protection. This paper expounded the current situation of protecting vulnerable groups from six aspects: inadequate protection of vulnerable groups by relevant laws and regulations, unclear definition of vulnerable groups, insufficient supervision by relevant departments, insufficient review ability of ethics committee to satisfy the protection of vulnerable groups, difficulty in fair inclusion of vulnerable groups, and the need to improve the ethical awareness of researchers and vulnerable groups. This paper also analyzed the new requirements for the protection of vulnerable groups in the Ethical Review Measures for Life Science and Medical Research Involving Humans from the following three aspects: expanding attention to potentially vulnerable research participants, paying more attention to the consent of research participants without or with limited capacity for civil conduct, and re-informed consent after the improvement of civil capacity level. Finally, suggestions on strengthening the protection of vulnerable groups were put forward from six aspects: improving the relevant legal system, clarifying the category of vulnerable groups, strengthening the implementation by regulatory departments, establishing a research participant protection system by research institutions, improving the ethical review capacity of ethics committees, formulating review guidelines by industry associations, and strengthening the education and training of all parties, so as to minimize the risk of vulnerable groups participating in clinical research and boost the quality and speed of clinical research in China.
8.Characteristics of the sleep-related beliefs in depressive patients comorbid with insomnia and its influence on sleep quality
Fanqiang MENG ; Lijuan YANG ; Juyi ZHANG ; Zhanjiang LI
Sichuan Mental Health 2022;35(4):319-324
ObjectiveTo explore the beliefs and attitudes about sleep in patients with comorbid depressive disorder and insomnia, and to explore its influence on sleep quality. MethodsPatients with comorbid depressive disorder and insomnia (n=61) and patients with primary insomnia (n=62) who met criteria specified in the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) in Beijing Anding Hospital Affiliated to Capital Medical University were enrolled, meantime, another 64 healthy controls were recruited. All subjects were assessed using Dysfunctional Beliefs and Attitudes about Sleep (DBAS) and Pittsburgh Sleep Quality Index (PSQI). Additionally, patients with comorbid depressive disorder and insomnia were evaluated using Hamilton Depression Scale-17 item (HAMD-17). The PSQI and DBAS scores were compared among three groups using analysis of covariance, and multiple linear regression analysis was used to screen the factors affecting PSQI score in patients with comorbid depressive disorder and insomnia. ResultsCompared with healthy controls, higher scores of PSQI (t=18.932, 18.610, P<0.01) along with lower scores of DBAS (t=-5.561, -5.791, P<0.01) were observed in patients with comorbid depressive disorder and insomnia and patients with primary insomnia. Taking the PSQI score of patients with comorbid depressive disorder and insomnia as the dependent variable, statistically significant equations were generated using multiple linear regression analysis (F=14.095, R2=0.327, P<0.05), and the predictive and control factors of sleep in DBAS and age were found to be the influencing factors of PSQI score in patients (B=-0.100, -0.279, P<0.05 or 0.01). ConclusionCompared with the normal,depression patients with insomnia have more dysfunctional beliefs and attitudes towards sleep,and dysfunctional cognition may be the influencing factor of their sleep quality.
9.Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine (Part 8): Quality Evaluation with AGREE Ⅱ and RIGHT
Fuqiang ZHANG ; Ziteng HU ; Yujing ZHANG ; Lijiao YAN ; Juyi WANG ; Cehan ZHANG ; Jiaqi CHEN ; Mengyi WANG ; Shuoming LIU ; Xinyi XIE ; Ning LIANG ; Nannan SHI ; Yanping WANG
Journal of Traditional Chinese Medicine 2024;65(2):185-191
ObjectiveTo evaluate the methodological and reporting quality of clinical practice guidelines for Chinese patent medicine (CPM) with internationally recognized tools the appraisal of guidelines for research and evaluation (AGEREE) Ⅱ and reporting items for practice guidelines in healthcare (RIGHT), thereby providing refe-rence for the clinical application and future development of CPM guidelines. MethodsDatabases including CNKI, VIP, Wanfang and Sinomed were searched for CPM guidelines, as well as medlive.cn, websites of China Association of Chinese Medicine and Chinese Medical Association, and reference lists of the included papers. The quality of the guidelines was evaluated using the AGREE Ⅱand RIGHT tools, and consistency tests were performed using Interclass Correlation Coefficient, and descriptive analysis and chi-square test were used to analyze the reporting rate for each domain and the average score for each item. ResultsFinally, 140 CPM guidelines were included, of which 51 were disease-oriented and 89 were drug-oriented, all of which were issued by China. For 51 disease-oriented CPM guidelines, the highest average score of all six AGREE Ⅱ domains was 73.32% for clarity, and the lowest was 26.80% for application; for 89 drug-oriented CPM guidelines, the highest average score was 55.62% for scope and purpose, and the lowest was 31.32% for rigour of development. In terms of the seven domains of the RIGHT checklist, the highest reporting rate was 68.26% for background, and lowest was 27.45% for other areas regarding the disease-oriented CPM guidelines; the highest reporting rate was 61.31% for background, and the lowest was 4.49% for other areas regarding drug-oriented CPM guidelines. The average reporting rate was higher for disease-oriented than drug-oriented CPM guidelines in three domains of AGREE Ⅱ (rigour of development, clarity of presentation, editorial independence), as well as four domains of RIGHT checklist (basic information, evidence, funding and declaration and management of interests, and other areas). ConclusionThe overall methodology and reporting quality of the current CPM guidelines still need to be improved. It is recommended that future guideline development teams should strictly refer to the AGREE Ⅱ and RIGHT checklist, and take into account of the characteristics of CPM guidelines and relevant methodo-logical suggestions in the development and reporting of CPM guidelines, thereby guiding the clinical use of CPM in a better way.
10.Establishment of Modified Aqueous Two-phase Extraction System of Polyphenols from Archidendron clypearia
Lixia GU ; Yongmei FU ; Shu ZHANG ; Juyi LIN ; Hong DENG ; Yongmei LU
China Pharmacy 2021;32(18):2236-2242
OBJECTIVE: To e stablish modified aqueous two-phase extraction (ATPE) system of polyphenols from Archidendron clypearia. METHODS :Taking the polyphenol content ,extraction efficiency and partition coefficient of A. clypearia as indexes ,the solid-liquid ratio ,ethanol mass fraction and ultrasonic time of ATPE system were selected by single factor tests . The aqueous two-phase extracts from different polar parts of A. clypearia was prepared. The modifier was selected by taking polyphenol content and antioxidant activity [IC 50 of 1,1-diphenyl-2-trinitrophenylhydrazine (DPPH), 2,2′-hydrazine bis (3-ethylbenzothiazole-6-sulfonic acid ) diammonium salt (ABTS)] as indicators ,combined with the grey correlation analysis between polyphenols and antioxidant activity. The effects of modified ATPE system with different mass fraction (0-90%)of modifier on the extraction of polyphenols from A. clypearia were investigated and compared with traditional extraction technology (ultrasonic extraction and heating reflux extraction ). RESULTS :The optimal ATPE system included solid-liquid ratio of 1 ∶ 45, ethanol mass fraction of 40%,(NH4)2SO4 mass fraction of 11%,ultrasonic extraction time of 20 min,at room temperature. In 3 validation tests ,polyphenol content ,extraction efficiency and partition coefficient were (28.35±1.01)%(RSD=3.56%,n=3), (98.87±0.19)%(RSD=0.19%,n=3)and 13.25±0.71(RSD=5.39%,n=3),respectively. The modifier was ethyl acetate. When the mass fraction of ethyl acetate in the ethyl acetate-ethanol mixed solvent was 70%,there was no significant difference in the content and anti-oxidant activity of polyphenols from A. clypearia of modified ATPE (P>0.05). The yield and transfer rate of it were si gnificantly higher than those of ultrasonic extraction and heating reflux extraction (P<0.05). CONCLUSIONS :The modified ATPE system with better extraction yield and transfer rate than the traditional extraction technology is successfully established,which can extract polyphenols from A. clypearia 1048214903@qq.com in one step.